MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $757,504 | +7.5% | 244,356 | -1.1% | 0.00% | – |
Q2 2023 | $704,415 | -52.5% | 247,163 | -34.3% | 0.00% | – |
Q1 2023 | $1,482,000 | +113376.3% | 376,054 | +14.1% | 0.00% | – |
Q4 2022 | $1,306 | -99.7% | 329,724 | +514.3% | 0.00% | – |
Q3 2022 | $493,000 | +2247.6% | 53,675 | +1416.7% | 0.00% | – |
Q2 2022 | $21,000 | -75.9% | 3,539 | -73.9% | 0.00% | – |
Q1 2022 | $87,000 | +89.1% | 13,580 | +94.7% | 0.00% | – |
Q4 2021 | $46,000 | +253.8% | 6,974 | +310.2% | 0.00% | – |
Q3 2020 | $13,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |